Salmeterol News
CHEST: Flovent/Serevent Combo Lowers Mortality In 'Landmark' COPD Trial
In what is being billed as a landmark trial, a combination of two drugs often used alone has increased survival, quality of life, and lung function in patients with chronic obstructive pulmonary disease, researchers said here.
BROVANA(TM) (Arformoterol Tartrate) Inhalation Solution Study Data Presented at American College of Chest Physicians Annual Conference
Sepracor Inc. today announced that it presented data from a Phase III pivotal trial of BROVANA(TM) (arformoterol tartrate) Inhalation Solution at CHEST 2006, the annual meeting of the American College of Chest Physicians (ACCP),...
Asthma drug effectiveness dependent on genes
Researchers believe that the effectiveness of from a commonly used asthma medicine may be compromised by a gene variation, which is present in around 13 per cent of the city’s population.
FDA Safety Changes: Serevent Diskus, Lotronex, Vfend CME/CE
The US Food and Drug Administration (FDA) has approved safety labeling revisions to advise that use of salmeterol xinafoate therapy may be linked to an increased risk for severe and potentially fatal asthma exacerbations; warn...
Question mark on asthma treatment
A common treatment for asthma may be having little effect on a large number of young people who have the condition. A gene variation present in some of the population means sufferers could be getting no benefit from the use of...
Displaying results 6 to 10 out of 14